Curtis Thompson

Bio

Dr. Curt Thompson is a senior nonclinical drug development expert with extensive experience in oncology, particularly in tumor microenvironment biology. With a focus on advancing programs from candidate selection through IND filing and into clinical support, Dr. Thompson has guided teams in navigating critical development decisions to minimize risk and avoid costly missteps.

Over the course of his career, Dr. Thompson has contributed to programs in oncology, inflammation, osteoarthritis, asthma, diabetes, and other disease areas—working across therapeutic modalities such as small molecules, antibodies, ADCs, RNAi, nanoparticles, and pegylated enzymes. He has led cross-functional teams, collaborated with academic and industry partners, and provided both strategic and scientific insight to drive go/no-go decisions.

Dr. Thompson holds a Master of Biotechnology Enterprise and Entrepreneurship (MBEE) from Johns Hopkins University, equipping him with the ability to bridge science and business. His expertise is especially valuable in startup and early-stage environments, where aligning innovation with strategic execution is key to success.